Medicale (MCLE) Invested Capital (2020 - 2025)
Medicale's Invested Capital history spans 6 years, with the latest figure at -$129416.0 for Q2 2025.
- For Q2 2025, Invested Capital fell 57.72% year-over-year to -$129416.0; the TTM value through Jun 2025 reached -$129416.0, down 57.72%, while the annual FY2024 figure was -$98933.0, 388.8% down from the prior year.
- Invested Capital reached -$129416.0 in Q2 2025 per MCLE's latest filing, down from -$123888.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $12108.0 in Q1 2021 to a low of -$129416.0 in Q2 2025.
- Average Invested Capital over 5 years is -$46952.9, with a median of -$26346.5 recorded in 2022.
- Peak YoY movement for Invested Capital: tumbled 1349.12% in 2022, then skyrocketed 45.3% in 2023.
- A 5-year view of Invested Capital shows it stood at -$15421.0 in 2021, then increased by 23.22% to -$11841.0 in 2022, then crashed by 406.94% to -$60027.0 in 2023, then plummeted by 92.6% to -$115613.0 in 2024, then dropped by 11.94% to -$129416.0 in 2025.
- Per Business Quant, the three most recent readings for MCLE's Invested Capital are -$129416.0 (Q2 2025), -$123888.0 (Q1 2025), and -$115613.0 (Q4 2024).